Overview

Drug-drug Interaction Between Digoxin, Furosemide, Metformin, and Rosuvastatin

Status:
Completed
Trial end date:
2015-01-01
Target enrollment:
0
Participant gender:
Male
Summary
To investigate the mutual interaction potential of digoxin, furosemide, metformin, and rosuvastatin when given alone or together as a cocktail, and to investigate the effect of high doses of metformin or furosemide on pharmacokinetics of the other cocktail compounds
Phase:
Phase 1
Accepts Healthy Volunteers?
Accepts Healthy Volunteers
Details
Lead Sponsor:
Boehringer Ingelheim
Treatments:
Digoxin
Furosemide
Metformin
Rosuvastatin Calcium
Criteria
Inclusion criteria:

1. Healthy male subjects according to the investigatorĀ“s assessment, based on a complete
medical history including a physical examination, vital signs (Blood Pressure, Pulse
Rate), 12-lead Electrocardiogram, and clinical laboratory tests

2. Age of 18 to 50 years (incl.)

3. Body Mass Index of 18.5 to 29.9 kg/m2 (incl.)

4. Signed and dated written informed consent prior to admission to the study in
accordance with Good Clinical Practice (GCP) and local legislation

Exclusion criteria:

1. Any finding in the medical examination (including Blood Pressure, Pulse Rate, or
Electrocardiogram) is deviating from normal and judged as clinically relevant by the
investigator

2. Repeated measurement of systolic blood pressure outside the range of 90 to 140 mmHg,
diastolic blood pressure outside the range of 50 to 90 mmHg, or pulse rate outside the
range of 50 to 90 bpm

3. Any laboratory value outside the reference range that the investigator considers to be
of clinical relevance

4. Any evidence of a concomitant disease judged as clinically relevant by the
investigator

5. Gastrointestinal, hepatic, renal, respiratory, cardiovascular, metabolic,
immunological, or hormonal disorders

6. Surgery of the gastrointestinal tract that could interfere with kinetics of the trial
medication (except appendectomy and simple hernia repair)

7. Diseases of the central nervous system (including but not limited to any kind of
seizures or stroke), and other relevant neurological or psychiatric disorders